Evidence map›Paper›PMID 37752806›Full record

ArticleCNS neuroscience & therapeutics2024

Neutral polysaccharide from Gastrodia elata alleviates cerebral ischemia-reperfusion injury by inhibiting ferroptosis-mediated neuroinflammation via the NRF2/HO-1 signaling pathway.

Yonggang Zhang, Peng Ye, Hua Zhu, Lijuan Gu, Yuntao Li, Shi Feng, Zhi Zeng, Qianxue Chen, Benhong Zhou, Xiaoxing Xiong

Abstract read
In one paragraph

Article in CNS neuroscience & therapeutics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 54 papers.

0numbers the graph read from it
0cells of the map it votes in
54citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

54 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Food science & nutrition · 2026
    Article
  10. Article
  11. Protective Effect ofInternational journal of molecular sciences · 2026
    Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Review
  18. Multi-omics reveals the protective mechanisms ofFrontiers in pharmacology · 2026
    Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Yonggang ZhangDepartment of Neurosurgery, Renmin Hospital of Wuhan University, Wuhan, China.
Peng YeDepartment of Pharmacy, Renmin Hospital of Wuhan University, Wuhan, China.
Hua ZhuDepartment of Neurosurgery, Renmin Hospital of Wuhan University, Wuhan, China.
Lijuan GuCentral Laboratory, Renmin Hospital of Wuhan University, Wuhan, China.ORCID 0000-0003-1928-8772
Yuntao LiDepartment of Neurosurgery, Renmin Hospital of Wuhan University, Wuhan, China.
Shi FengDepartment of Neurosurgery, Renmin Hospital of Wuhan University, Wuhan, China.
Zhi ZengDepartment of Pathology, Renmin Hospital of Wuhan University, Wuhan, China.
Qianxue ChenDepartment of Neurosurgery, Renmin Hospital of Wuhan University, Wuhan, China.ORCID 0000-0002-9413-1030
Benhong ZhouDepartment of Pharmacy, Renmin Hospital of Wuhan University, Wuhan, China.
Xiaoxing XiongDepartment of Neurosurgery, Renmin Hospital of Wuhan University, Wuhan, China.ORCID 0000-0001-6983-8547

Funding

National Natural Science Foundation of China 81503051National Natural Science Foundation of China 81870939National Natural Science Foundation of China 82171336National Natural Science Foundation of China 82271370National Natural Science Foundation of China 82371346
6 · The paper itself

Abstract

aimsThe crosstalk between ferroptosis and neuroinflammation considerably impacts the pathogenesis of cerebral ischemia-reperfusion injury (CIRI). Neutral polysaccharide from Gastrodia elata (NPGE) has shown significant effects against oxidative stress and inflammation. This study investigated the potential effects of NPGE on CIRI neuropathology.

methodsThe effects of NPGE were studied in a mouse model of ischemic stroke (IS) and in oxygen-glucose deprivation/reperfusion (OGD/R)-induced HT22 cells.

resultsNPGE treatment decreased neurological deficits, reduced infarct volume, and alleviated cerebral edema in IS mice, and promoted the survival of OGD/R-induced HT22 cells. Mechanistically, NPGE treatment alleviated neuronal ferroptosis by upregulating GPX4 levels, lowering reactive oxygen species (ROS), malondialdehyde (MDA), and Fe

conclusionCollectively, our results demonstrate the protective effects of NPGE and highlight its therapeutic potential as a drug component for CIRI treatment.

Indexed as

FerroptosisGastrodiaReperfusion InjuryAnimalsCerebral InfarctionGlucoseInflammationMiceNeuroinflammatory DiseasesNF-E2-Related Factor 2Oxidative StressSignal TransductionGlucoseNF-E2-Related Factor 2ferroptosisischemic strokeneuroinflammationneutral polysaccharide from Gastrodia elataNRF2/HO-1 signaling pathway

Identifiers

PMID37752806
PMCPMC10916450

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.